Related Experiment Video
Updated: Jul 10, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
An account of the current status of point-of-care lateral flow tests for kidney biomarker detection
Tileshwar Sahare1, Badri Narayana Sahoo1, Surbhi Jaiswal1
1Department of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, Khandwa Road, Simrol, Indore - 453552, Madhya Pradesh, India. abhijeet.joshi@iiti.ac.in.
Insights
This review highlights lateral flow tests (LFTs) for detecting kidney disease biomarkers. These point-of-care biosensors offer a cost-effective, sensitive, and rapid method for diagnosing and monitoring conditions like acute kidney injury (AKI) and chronic kidney disease (CKD).
Area of Science:
- Biomedical Engineering
- Clinical Chemistry
- Point-of-Care Diagnostics
Background:
- Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) are leading causes of global mortality and morbidity.
- Non-invasive monitoring is crucial for managing chronic kidney diseases.
- Biomarker detection offers significant potential for improving patient survival and reducing healthcare costs.
Purpose of the Study:
- To review recent advancements in using lateral flow tests (LFTs) for renal biomarker detection.
- To discuss challenges and opportunities in developing point-of-care (POC) diagnostic tools for kidney diseases.
- To explore methods for enhancing the sensitivity of LFTs for improved diagnostic accuracy.
Main Methods:
- Review of current literature on lateral flow test strip (LFT) technology for kidney disease biomarkers.
- Analysis of different approaches for sensitivity enhancement in POC diagnostic devices.
- Evaluation of ideal characteristics for point-of-care lateral flow tests, including cost-effectiveness, sensitivity, specificity, ease of use, and speed.
Main Results:
- Lateral flow tests (LFTs) are identified as highly desirable point-of-care instruments for kidney disease diagnostics.
- Recent developments show promise in improving the sensitivity and specificity of LFTs for biomarker detection.
- The review details various strategies to enhance LFT performance for effective renal biomarker identification.
Conclusions:
- LFTs represent a significant advancement in point-of-care diagnostics for kidney diseases, offering rapid and accessible testing.
- Further research and development in sensitivity enhancement and quality control are crucial for optimizing LFTs.
- Future advancements in POC and LFT kits hold the potential to revolutionize kidney disease management and patient outcomes.
Abstract:
Globally, the primary causes of mortality and morbidity related to kidney ailments can be classified as Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). Biomarker detection can have great potential to improve survival, lower mortality, and reduce the cost of treatment of kidney diseases. Considering the chronic nature of CKD, non-invasive identification and monitoring have proven to be useful. Biosensors and more specifically lateral flow test strips (LFTs) are regarded as the most desirable point-of-care instruments which have shown promise in elevating the healthcare industry to a new level. The major aspects of an ideal point-of-care (POC) lateral flow test include its cost effectiveness, high sensitivity and specificity, ease of use, quick result delivery, and quality control. This review provides a detailed account of recent developments, challenges, and opportunities in renal biomarker detection using LFTs including various approaches for sensitivity enhancement along with potential future advancements in POC and LFT kits.
Related Concept Videos
Testing Water Quality
Methods to Assess Microbial Populations
Microbial Biosensors
Biological Treatment of Effluent and Waste Water
Automated Microbial Diagnostics

